Research programme: thyroid hormone analogues - Octamer
Alternative Names: DIME; DIPE; Thyroid hormone analogues research programme - OctamerLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Octamer
- Class Hormones
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 03 Mar 2004 Thyroid hormone analogs research programme has been licensed to Crimson Pharma in China, Korea, Hong Kong, Taiwan, Singapore, and other countries and regions in Southeast Asia
- 29 Jul 2003 Preclinical trials in Cancer in USA (unspecified route)